🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 8 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| 14/12/2022 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 06/05/1997 | 43,65 | 44,43 | 43,65 | 43,89 | +0,55% | 1,78% | 7.872.786 |
| 05/05/1997 | 43,54 | 44,07 | 43,12 | 43,65 | +0,55% | 2,19% | 6.822.690 |
| 02/05/1997 | 42,58 | 43,48 | 42,52 | 43,42 | +2,25% | 2,24% | 5.674.291 |
| 01/05/1997 | 43,00 | 43,42 | 42,34 | 42,46 | -1,52% | 2,50% | 5.152.597 |
| 30/04/1997 | 43,36 | 43,83 | 42,94 | 43,12 | -1,23% | 2,06% | 7.388.610 |
| 29/04/1997 | 42,88 | 43,77 | 42,64 | 43,65 | +3,10% | 2,64% | 6.079.658 |
| 28/04/1997 | 41,87 | 42,52 | 41,75 | 42,34 | +1,57% | 1,85% | 3.775.525 |
| 25/04/1997 | 41,51 | 41,87 | 41,33 | 41,69 | +0,29% | 1,29% | 3.040.248 |
| 24/04/1997 | 42,04 | 42,22 | 41,21 | 41,57 | -0,71% | 2,41% | 4.383.994 |
| 23/04/1997 | 42,58 | 42,64 | 41,81 | 41,87 | -1,68% | 1,96% | 6.002.944 |
| 22/04/1997 | 41,45 | 42,70 | 41,33 | 42,58 | +3,18% | 3,31% | 6.778.883 |
| 21/04/1997 | 41,39 | 41,75 | 40,85 | 41,27 | -0,14% | 2,16% | 4.474.541 |
| 18/04/1997 | 41,15 | 41,45 | 40,79 | 41,33 | +0,43% | 1,59% | 5.724.176 |
| 17/04/1997 | 40,79 | 41,33 | 40,55 | 41,15 | +0,73% | 1,90% | 5.867.542 |
| 16/04/1997 | 40,43 | 41,15 | 40,08 | 40,85 | +1,33% | 2,65% | 7.143.797 |
| 15/04/1997 | 39,96 | 40,43 | 39,60 | 40,31 | +2,27% | 2,09% | 7.630.698 |
| 14/04/1997 | 38,94 | 39,54 | 38,47 | 39,42 | +1,07% | 2,76% | 6.538.472 |
| 11/04/1997 | 39,42 | 39,78 | 39,00 | 39,00 | -2,24% | 1,97% | 6.808.646 |
| 10/04/1997 | 39,24 | 40,08 | 39,18 | 39,90 | +2,61% | 2,28% | 10.913.034 |
| 09/04/1997 | 39,12 | 39,24 | 38,35 | 38,88 | -4,40% | 2,29% | 21.814.749 |
| 08/04/1997 | 41,33 | 41,33 | 39,84 | 40,67 | -1,59% | 3,61% | 5.764.210 |
| 07/04/1997 | 41,98 | 42,04 | 41,27 | 41,33 | -0,29% | 1,85% | 4.384.622 |
| 04/04/1997 | 40,37 | 41,69 | 40,26 | 41,45 | +1,91% | 3,55% | 6.600.094 |
| 03/04/1997 | 40,08 | 40,73 | 39,96 | 40,67 | -0,15% | 1,93% | 6.376.870 |
| 02/04/1997 | 41,27 | 41,39 | 40,49 | 40,73 | -1,44% | 2,17% | 5.134.362 |
| 01/04/1997 | 40,08 | 41,45 | 39,90 | 41,33 | +2,82% | 3,87% | 9.848.266 |
| 31/03/1997 | 42,16 | 42,22 | 39,54 | 40,20 | -5,20% | 6,36% | 10.961.870 |
| 27/03/1997 | 43,36 | 43,54 | 41,57 | 42,40 | -2,20% | 4,54% | 6.247.966 |
| 26/03/1997 | 43,54 | 44,07 | 43,24 | 43,36 | -0,14% | 1,92% | 4.747.021 |
| 25/03/1997 | 42,94 | 43,95 | 42,76 | 43,42 | +1,25% | 2,78% | 6.870.269 |